| Autor: |
Profita M; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy. Electronic address: profita@ibim.cnr.it., Albano GD; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy; Dipartimento Biomedico di Medicina, Interna e Specialistica (Di.Bi.M.I.S.), Sezione di Pneumologia, University of Palermo, Palermo, Italy., Riccobono L; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Di Sano C; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Montalbano AM; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Gagliardo R; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Anzalone G; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Bonanno A; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy., Pieper MP; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Gjomarkaj M; Unit: 'Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases', Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy. |
Full Text from ScienceDirect